Int J Cardiol. 2011 Apr 1;148(1):e7-9. doi: 10.1016/j.ijcard.2009.01.055. Epub 2009 Feb 23.
Evidence demonstrating the potential value of cardiopulmonary exercise testing (CPET) to accurately detect myocardial ischemia secondary to macro-vascular disease is beginning to emerge. Despite distinct mechanisms mediating ischemia in micro-vascular and macrovascular coronary artery disease (CAD), the net physiologic effect of exercise-induced left ventricular (LV) dysfunction is common to both. The abnormal physiologic response to CPET may, therefore, be similar in patients with macro- and micro-vascular ischemia. The following case report describes the CPET abnormalities in a patient with suspected microvascular CAD and the subsequent improvement in LV function following three weeks of medical therapy with the anti-ischemic drug ranolazine.
有证据表明,心肺运动测试(CPET)具有潜在的价值,可以准确检测到由大血管疾病引起的心肌缺血。尽管微血管和大血管冠状动脉疾病(CAD)的缺血机制不同,但运动引起的左心室(LV)功能障碍的净生理效应对两者都是共同的。因此,患有大血管和微血管缺血的患者的 CPET 异常可能相似。以下病例报告描述了一名疑似微血管 CAD 患者的 CPET 异常情况,以及随后在接受抗缺血药物雷诺嗪治疗 3 周后 LV 功能的改善。